Study directory

Schizophrenia studies

Compare studies and check their requirements with the research team.

Back to overview
More filters: keywords, city, remote
4306studies shown
Showing 1,417-1,428 of 4,306
Behavioral study icon
CompletedNCT02386605

Motivational Negative Symptoms in Schizophrenia: Intervention and Biomarkers

This summary needs review. Please check the official study record and contact the research team for details.

In West Los Angeles
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaBehavioralFrom 18 Years to 65 Years
Countries
United States
Sponsor
VA Office of Research and Development
Condition
Schizophrenia
Device study icon
Active Not RecruitingNCT01941251

Navigated αTMS in Treatment-resistant Schizophrenia

This summary needs review. Please check the official study record and contact the research team for details.

In Kuopio
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaDeviceA study involving a tool, app, wearable, test, or medical device.From 18 Years to 64 Years
Countries
Finland
Sponsor
Niuvanniemi Hospital
Condition
Schizophrenia
Behavioral study icon
CompletedNCT01975584

Neuroendocrine and Immune Response to Stress in Schizophrenia

This summary needs review. Please check the official study record and contact the research team for details.

In Catonsville
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaBehavioralFrom 18 Years to 64 Years
Countries
United States
Sponsor
University of Maryland, Baltimore
Condition
Schizophrenia
Drug study icon
CompletedNCT00320723

Nicotine Replacement Therapy for Smoking Cessation in Schizophrenia

This summary needs review. Please check the official study record and contact the research team for details.

In Boston
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaDrugA study involving a medication or substance.From 18 Years to 70 Years
Countries
United States
Sponsor
North Suffolk Mental Health Association
Condition
Schizophrenia
Behavioral study icon
CompletedNCT02069392

Nicotinic Enhancement of Cognitive Remediation Training in Schizophrenia

This summary needs review. Please check the official study record and contact the research team for details.

In Baltimore
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaBehavioralFrom 18 Years to 60 Years
Countries
United States
Sponsor
University of Maryland, Baltimore
Condition
Schizophrenia
Drug study icon
CompletedNCT01400477

Nicotinic Receptors and Schizophrenia

This summary needs review. Please check the official study record and contact the research team for details.

In Aurora
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaDrugFrom 18 Years to 65 Years
Countries
United States
Sponsor
University of Colorado, Denver
Condition
Schizophrenia
Other study type icon
CompletedNCT01875822

Study of Curcumin C-3 Complex in Schizophrenia

This study is completed in the United States. It is testing Curcumin C-3 Complex for schizophrenia.

In San Juan
Why is this study shown?

This study is directly about Schizophrenia.

Schizophrenia, DepressionOtherFrom 18 Years to 65 Years
Countries
United States
Sponsor
Woodbury, Michel, M.D.
Condition
Schizophrenia, Depression
Drug study icon
CompletedNCT01248195

Optimization of Treatment and Management of Schizophrenia in Europe

This summary needs review. Please check the official study record and contact the research team for details.

Multiple locations, including Melbourne
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaDrugFrom 18 Years to 40 Years
Countries
Australia, France, United Kingdom, ...
Sponsor
Rene Kahn
Condition
Schizophrenia
Drug study icon
CompletedNCT01752712

Oxytocin and CBSST for People With Schizophrenia

This summary needs review. Please check the official study record and contact the research team for details.

Multiple locations, including San Diego
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaDrugFrom 18 Years to 55 Years
Countries
United States
Sponsor
University of Maryland, Baltimore
Condition
Schizophrenia
Drug study icon
CompletedNCT01028677

Oxytocin Treatment of Schizophrenia

This summary needs review. Please check the official study record and contact the research team for details.

In Chapel Hill
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaDrugFrom 18 Years to 55 Years
Countries
United States
Sponsor
University of North Carolina, Chapel Hill
Condition
Schizophrenia
Data coverage

Public registry coverage is progressing

HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.